Verve Therapeutics, Inc.

NASDAQ:VERV

5.46 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 141.49144.2206.1878.3770.042508.687115.412550.7172.88991.4264.33148.134387.44699.3978.993-18.782
Short Term Investments 434.458462.167417.77406.856392.434424.941439.396273.691220.672231.879296.112241.07630.17850.12663.11937.564
Cash and Short Term Investments 575.948606.367623.95485.226462.476508.687554.808550.71293.561323.299360.442389.21417.624149.52372.11218.782
Net Receivables 3.045.7675.8973.1452.0931.4041.0120.92900000000
Inventory 00000-9.10000000000
Other Current Assets 11.8998.1928.1029.898.4977.6967.3399.9915.0835.5316.6865.2271.942.3181.8540
Total Current Assets 590.887620.326637.949498.261473.066508.687563.159561.63298.644328.83367.128394.437419.564151.84173.96618.782
Non-Current Assets:
Property, Plant & Equipment, Net 101.931104.551107.8107.844110.018111.056110.655106.49113.19312.4729.0638.9096.4175.2023.9840
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 4.7744.7744.7744.7744.8244.8244.8244.8245.2375.2375.2375.2370.4630.46300
Tax Assets 0000000000000000
Other Non-Current Assets 3.3182.7062.1651.5281.2239.8090.5850.417.1932.7022.6962.2940.0740.6630.463-18.782
Total Non-Current Assets 110.023112.031114.739114.146116.065125.689116.064111.72525.62320.41116.99616.446.9546.3284.447-18.782
Total Assets 700.91732.357752.688612.407589.131634.376679.223673.355324.267349.241384.124410.877426.518158.16978.4130
Liabilities & Equity:
Current Liabilities:
Account Payables 6.8333.0496.6361.0543.1463.3722.4240.4656.322.43820.0693.5791.532.4870.0360
Short Term Debt 10.29310.2210.19210.11810.04611.18411.9048.9040.9071.4321.9552.295-0.152-0.13600
Tax Payables 0000000000000000
Deferred Revenue 3.4791.47348.55648.55420.01420.01420.01420.01400-12.9928.1270.1520.13600
Other Current Liabilities 19.76216.552-28.378-25.151-0.175-1.0180.753-0.36518.6210.93312.9926.257.1194.1977.2790
Total Current Liabilities 40.36731.29437.00634.57533.03133.55235.09529.01825.84714.80322.02420.2518.6496.6847.3150
Non-Current Liabilities:
Long Term Debt 62.18363.45464.71566.68967.81968.92770.01471.0110.90701.9550.1810218.91900
Deferred Revenue Non-Current 51.15351.73348.55648.55420.01420.01420.01420.01400000.0130.05300
Deferred Tax Liabilities Non-Current 0000000000000-218.97200
Other Non-Current Liabilities 1.1132.8072.9092.223.0452.4073.1685.3691.183.0482.7935.5112.46227.916135.0070
Total Non-Current Liabilities 114.449117.994116.18117.46390.87891.34893.19696.3942.0873.0484.7485.69112.473227.916135.0070
Total Liabilities 154.816149.288153.186152.038123.909124.9128.291125.41227.93417.85126.77225.94221.122234.6142.3220
Equity:
Preferred Stock 00000000000410.877426.518218.919125.1625.48
Common Stock 0.0850.0840.0820.0640.0620.0620.0620.0610.0490.0490.0490.0480.0480.0030.0030
Retained Earnings -642.846-593.041-544.305-495.953-450.195-396.212-344.237-303.152-257.962-217.016-186.85-155.513-132.764-79.799-66.5360
Accumulated Other Comprehensive Income/Loss -0.615-0.50.272-0.597-0.754-0.237-0.694-0.92-0.938-0.732-0.228-0.0020.0030.0070.008-19.553
Other Total Stockholders Equity 1,189.471,176.5261,143.453956.855916.109905.863895.801851.954555.184549.089544.381129.525111.591-215.561-122.5440
Total Shareholders Equity 546.094583.069599.502460.369465.222509.476550.932547.943296.333331.39357.352384.935405.396-76.431-63.9095.927
Total Equity 546.094583.069599.502460.369465.222509.476550.932547.943296.333331.39357.352384.935405.396-76.431-63.9095.927
Total Liabilities & Shareholders Equity 700.91732.357752.688612.407589.131634.376679.223673.355324.267349.241384.124410.877426.518158.16978.4135.927